Skip to main content
Top
Published in: BMC Medicine 1/2012

Open Access 01-12-2012 | Review

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

Authors: Michael Maes, Michael Berk, Lisa Goehler, Cai Song, George Anderson, Piotr Gałecki, Brian Leonard

Published in: BMC Medicine | Issue 1/2012

Login to get access

Abstract

It is of considerable translational importance whether depression is a form or a consequence of sickness behavior. Sickness behavior is a behavioral complex induced by infections and immune trauma and mediated by pro-inflammatory cytokines. It is an adaptive response that enhances recovery by conserving energy to combat acute inflammation. There are considerable phenomenological similarities between sickness behavior and depression, for example, behavioral inhibition, anorexia and weight loss, and melancholic (anhedonia), physio-somatic (fatigue, hyperalgesia, malaise), anxiety and neurocognitive symptoms. In clinical depression, however, a transition occurs to sensitization of immuno-inflammatory pathways, progressive damage by oxidative and nitrosative stress to lipids, proteins, and DNA, and autoimmune responses directed against self-epitopes. The latter mechanisms are the substrate of a neuroprogressive process, whereby multiple depressive episodes cause neural tissue damage and consequent functional and cognitive sequelae. Thus, shared immuno-inflammatory pathways underpin the physiology of sickness behavior and the pathophysiology of clinical depression explaining their partially overlapping phenomenology. Inflammation may provoke a Janus-faced response with a good, acute side, generating protective inflammation through sickness behavior and a bad, chronic side, for example, clinical depression, a lifelong disorder with positive feedback loops between (neuro)inflammation and (neuro)degenerative processes following less well defined triggers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maes M: A review on the acute phase response in major depression. Rev Neurosci. 1993, 4: 407-416.PubMed Maes M: A review on the acute phase response in major depression. Rev Neurosci. 1993, 4: 407-416.PubMed
2.
go back to reference Maes M, Meltzer HY, Scharpe S, Cooreman W, Uyttenbroeck W, Suy E, Vandervorst C, Calabrese J, Raus J, Cosyns P: Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Res. 1993, 47: 229-241. 10.1016/0165-1781(93)90081-Q.PubMed Maes M, Meltzer HY, Scharpe S, Cooreman W, Uyttenbroeck W, Suy E, Vandervorst C, Calabrese J, Raus J, Cosyns P: Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Res. 1993, 47: 229-241. 10.1016/0165-1781(93)90081-Q.PubMed
3.
go back to reference Holmes JE, Miller NE: Effects of bacterial endotoxin on water intake, food intake, and body temperature in the albino rat. J Exp Med. 1963, 118: 649-658. 10.1084/jem.118.4.649.PubMedPubMedCentral Holmes JE, Miller NE: Effects of bacterial endotoxin on water intake, food intake, and body temperature in the albino rat. J Exp Med. 1963, 118: 649-658. 10.1084/jem.118.4.649.PubMedPubMedCentral
4.
go back to reference Hart BL: Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988, 12: 123-137. 10.1016/S0149-7634(88)80004-6.PubMed Hart BL: Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988, 12: 123-137. 10.1016/S0149-7634(88)80004-6.PubMed
5.
go back to reference Maier SF, Wiertelak EP, Martin D, Watkins LR: Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 1993, 623: 321-324. 10.1016/0006-8993(93)91446-Y.PubMed Maier SF, Wiertelak EP, Martin D, Watkins LR: Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 1993, 623: 321-324. 10.1016/0006-8993(93)91446-Y.PubMed
6.
go back to reference Yirmiya R: Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711: 163-174. 10.1016/0006-8993(95)01415-2.PubMed Yirmiya R: Endotoxin produces a depressive-like episode in rats. Brain Res. 1996, 711: 163-174. 10.1016/0006-8993(95)01415-2.PubMed
7.
go back to reference Johnson RW: The concept of sickness behavior: a brief chronological account of four key discoveries. Vet Immunol Immunopathol. 2002, 87: 443-450. 10.1016/S0165-2427(02)00069-7.PubMed Johnson RW: The concept of sickness behavior: a brief chronological account of four key discoveries. Vet Immunol Immunopathol. 2002, 87: 443-450. 10.1016/S0165-2427(02)00069-7.PubMed
8.
go back to reference Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT: Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007, 55: 453-462. 10.1002/glia.20467.PubMedPubMedCentral Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT: Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007, 55: 453-462. 10.1002/glia.20467.PubMedPubMedCentral
9.
go back to reference Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008, 9: 46-56. 10.1038/nrn2297.PubMedPubMedCentral Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008, 9: 46-56. 10.1038/nrn2297.PubMedPubMedCentral
10.
go back to reference Burton MD, Sparkman NL, Johnson RW: Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior. J Neuroinflammation. 2011, 8: 54-10.1186/1742-2094-8-54.PubMedPubMedCentral Burton MD, Sparkman NL, Johnson RW: Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior. J Neuroinflammation. 2011, 8: 54-10.1186/1742-2094-8-54.PubMedPubMedCentral
11.
go back to reference Maes M: Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995, 19: 11-38. 10.1016/0278-5846(94)00101-M.PubMed Maes M: Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995, 19: 11-38. 10.1016/0278-5846(94)00101-M.PubMed
12.
go back to reference Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J: Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand. 1991, 84: 379-386. 10.1111/j.1600-0447.1991.tb03163.x.PubMed Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J: Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand. 1991, 84: 379-386. 10.1111/j.1600-0447.1991.tb03163.x.PubMed
13.
go back to reference Maes M, Scharpe S, Bosmans E, Vandewoude M, Suy E, Uyttenbroeck W, Cooreman W, Vandervorst C, Raus J: Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry. 1992, 16: 501-515. 10.1016/0278-5846(92)90056-K.PubMed Maes M, Scharpe S, Bosmans E, Vandewoude M, Suy E, Uyttenbroeck W, Cooreman W, Vandervorst C, Raus J: Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry. 1992, 16: 501-515. 10.1016/0278-5846(92)90056-K.PubMed
14.
go back to reference Song C, Dinan T, Leonard BE: Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord. 1994, 30: 283-288. 10.1016/0165-0327(94)90135-X.PubMed Song C, Dinan T, Leonard BE: Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord. 1994, 30: 283-288. 10.1016/0165-0327(94)90135-X.PubMed
15.
go back to reference Leonard B, Maes M: Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012, 36: 764-785. 10.1016/j.neubiorev.2011.12.005.PubMed Leonard B, Maes M: Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012, 36: 764-785. 10.1016/j.neubiorev.2011.12.005.PubMed
16.
go back to reference Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, Berk L, Conus P, McGorry PD: Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011, 13: 87-98. 10.1111/j.1399-5618.2011.00889.x.PubMed Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, Berk L, Conus P, McGorry PD: Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011, 13: 87-98. 10.1111/j.1399-5618.2011.00889.x.PubMed
17.
go back to reference Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, McGorry P, Malhi GS: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011, 35: 804-817. 10.1016/j.neubiorev.2010.10.001.PubMed Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, McGorry P, Malhi GS: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011, 35: 804-817. 10.1016/j.neubiorev.2010.10.001.PubMed
18.
go back to reference Maes M, Mihaylova I, Kubera M, Ringel K: Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2012, 36: 169-175. 10.1016/j.pnpbp.2011.09.006.PubMed Maes M, Mihaylova I, Kubera M, Ringel K: Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2012, 36: 169-175. 10.1016/j.pnpbp.2011.09.006.PubMed
19.
go back to reference Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL: A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010, 67: 446-457. 10.1016/j.biopsych.2009.09.033.PubMed Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL: A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010, 67: 446-457. 10.1016/j.biopsych.2009.09.033.PubMed
20.
go back to reference Liu Y, Ho RC, Mak A: Interleukin (IL)-6, tumour necrosis factor alpha (TNF-αa) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012, 139: 230-239. 10.1016/j.jad.2011.08.003.PubMed Liu Y, Ho RC, Mak A: Interleukin (IL)-6, tumour necrosis factor alpha (TNF-αa) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012, 139: 230-239. 10.1016/j.jad.2011.08.003.PubMed
21.
go back to reference Medzhitov R: Inflammation 2010: new adventures of an old flame. Cell. 2010, 140: 771-776. 10.1016/j.cell.2010.03.006.PubMed Medzhitov R: Inflammation 2010: new adventures of an old flame. Cell. 2010, 140: 771-776. 10.1016/j.cell.2010.03.006.PubMed
22.
go back to reference Peters A: The energy request of inflammation. Endocrinology. 2006, 147: 4550-4552. 10.1210/en.2006-0815.PubMed Peters A: The energy request of inflammation. Endocrinology. 2006, 147: 4550-4552. 10.1210/en.2006-0815.PubMed
23.
go back to reference Steinberg GR, Watt MJ, Febbraio MA: Cytokine regulation of AMPK signalling. Front Biosci. 2009, 14: 1902-1916. Steinberg GR, Watt MJ, Febbraio MA: Cytokine regulation of AMPK signalling. Front Biosci. 2009, 14: 1902-1916.
24.
go back to reference Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, Dinarello CA, Rosenberg IH: Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994, 93: 2379-2386. 10.1172/JCI117244.PubMedPubMedCentral Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, Dinarello CA, Rosenberg IH: Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994, 93: 2379-2386. 10.1172/JCI117244.PubMedPubMedCentral
25.
go back to reference Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J: Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett. 2011, 32: 7-24.PubMed Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J: Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett. 2011, 32: 7-24.PubMed
26.
go back to reference Charlton BG: The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic. Med Hypotheses. 2000, 54: 126-30. 10.1054/mehy.1999.0986.PubMed Charlton BG: The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic. Med Hypotheses. 2000, 54: 126-30. 10.1054/mehy.1999.0986.PubMed
27.
go back to reference Cunningham-Rundles S, McNeeley DF, Moon A: Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol. 2005, 115: 1119-1128. 10.1016/j.jaci.2005.04.036.PubMed Cunningham-Rundles S, McNeeley DF, Moon A: Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol. 2005, 115: 1119-1128. 10.1016/j.jaci.2005.04.036.PubMed
29.
go back to reference Schaffner A: Fever--useful or noxious symptom that should be treated?. Ther Umsch. 2006, 63: 185-188. 10.1024/0040-5930.63.3.185.PubMed Schaffner A: Fever--useful or noxious symptom that should be treated?. Ther Umsch. 2006, 63: 185-188. 10.1024/0040-5930.63.3.185.PubMed
30.
go back to reference Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J: Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J Infect. 2009, 58: 266-272. 10.1016/j.jinf.2009.01.015.PubMed Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J: Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J Infect. 2009, 58: 266-272. 10.1016/j.jinf.2009.01.015.PubMed
31.
go back to reference El-Radhi AS: The role of fever in the past and present. Med J Islamic World Acad Sci. 2011, 19: 9-14. El-Radhi AS: The role of fever in the past and present. Med J Islamic World Acad Sci. 2011, 19: 9-14.
32.
go back to reference Harden LM, du Plessis I, Roth J, Loram LC, Poole S, Laburn HP: Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-1β and prostanoids in mediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology. 2011, 36: 608-622. 10.1016/j.psyneuen.2010.09.003.PubMed Harden LM, du Plessis I, Roth J, Loram LC, Poole S, Laburn HP: Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-1β and prostanoids in mediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology. 2011, 36: 608-622. 10.1016/j.psyneuen.2010.09.003.PubMed
33.
go back to reference Lennie TA: Relationship of body energy status to inflammation-induced anorexia and weight loss. Physiol Behav. 1998, 64: 475-481. 10.1016/S0031-9384(98)00103-6.PubMed Lennie TA: Relationship of body energy status to inflammation-induced anorexia and weight loss. Physiol Behav. 1998, 64: 475-481. 10.1016/S0031-9384(98)00103-6.PubMed
34.
go back to reference Kluger MJ, Rothenburg BA: Fever and reduced iron: their interaction as a host defense response to bacterial infection. Science. 1979, 203: 374-376. 10.1126/science.760197.PubMed Kluger MJ, Rothenburg BA: Fever and reduced iron: their interaction as a host defense response to bacterial infection. Science. 1979, 203: 374-376. 10.1126/science.760197.PubMed
35.
go back to reference Jung KJ, Lee EK, Kim JY, Zou Y, Sung B, Heo HS, Kim MK, Lee J, Kim ND, Yu BP, Chung HY: Effect of short term calorie restriction on pro-inflammatory NF-kB and AP-1 in aged rat kidney. Inflamm Res. 2009, 58: 143-150. 10.1007/s00011-008-7227-2.PubMed Jung KJ, Lee EK, Kim JY, Zou Y, Sung B, Heo HS, Kim MK, Lee J, Kim ND, Yu BP, Chung HY: Effect of short term calorie restriction on pro-inflammatory NF-kB and AP-1 in aged rat kidney. Inflamm Res. 2009, 58: 143-150. 10.1007/s00011-008-7227-2.PubMed
36.
go back to reference MacDonald L, Radler M, Paolini AG, Kent S: Calorie restriction attenuates LPS-induced sickness behavior and shifts hypothalamic signaling pathways to an anti-inflammatory bias. Am J Physiol Regul Integr Comp Physiol. 2011, 301: R172-184. 10.1152/ajpregu.00057.2011.PubMed MacDonald L, Radler M, Paolini AG, Kent S: Calorie restriction attenuates LPS-induced sickness behavior and shifts hypothalamic signaling pathways to an anti-inflammatory bias. Am J Physiol Regul Integr Comp Physiol. 2011, 301: R172-184. 10.1152/ajpregu.00057.2011.PubMed
37.
go back to reference Bosutti A, Malaponte G, Zanetti M, Castellino P, Heer M, Guarnieri G, Biolo G: Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. J Clin Endocrinol Metab. 2008, 93: 3226-3229. 10.1210/jc.2007-1684.PubMed Bosutti A, Malaponte G, Zanetti M, Castellino P, Heer M, Guarnieri G, Biolo G: Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. J Clin Endocrinol Metab. 2008, 93: 3226-3229. 10.1210/jc.2007-1684.PubMed
38.
go back to reference Kopp HP, Kopp CW, Festa A, Krzyzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G: Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003, 23: 1042-1047. 10.1161/01.ATV.0000073313.16135.21.PubMed Kopp HP, Kopp CW, Festa A, Krzyzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G: Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003, 23: 1042-1047. 10.1161/01.ATV.0000073313.16135.21.PubMed
39.
go back to reference Jellema A, Plat J, Mensink RP: Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest. 2004, 34: 766-773. 10.1111/j.1365-2362.2004.01414.x.PubMed Jellema A, Plat J, Mensink RP: Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest. 2004, 34: 766-773. 10.1111/j.1365-2362.2004.01414.x.PubMed
40.
go back to reference Sharman MJ, Volek JS: Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond). 2004, 107: 365-369. 10.1042/CS20040111. Sharman MJ, Volek JS: Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond). 2004, 107: 365-369. 10.1042/CS20040111.
41.
go back to reference Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2002, 86: 3815-3819. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2002, 86: 3815-3819.
42.
go back to reference Maes M, Maes L, Schotte C, Vandewoude M, Martin M, D'Hondt P, Blockx P, Scharpé S, Cosyns P: Clinical subtypes of unipolar depression: part III. quantitative differences in various biological markers between the cluster-analytically generated nonvital and vital depression classes. Psychiatry Res. 1990, 34: 59-75. 10.1016/0165-1781(90)90058-D.PubMed Maes M, Maes L, Schotte C, Vandewoude M, Martin M, D'Hondt P, Blockx P, Scharpé S, Cosyns P: Clinical subtypes of unipolar depression: part III. quantitative differences in various biological markers between the cluster-analytically generated nonvital and vital depression classes. Psychiatry Res. 1990, 34: 59-75. 10.1016/0165-1781(90)90058-D.PubMed
43.
go back to reference Maes M, Meltzer HY, Cosyns P, Schotte C: Evidence for the existence of major depression with and without anxiety features. Psychopathology. 1994, 27: 1-13. 10.1159/000284842.PubMed Maes M, Meltzer HY, Cosyns P, Schotte C: Evidence for the existence of major depression with and without anxiety features. Psychopathology. 1994, 27: 1-13. 10.1159/000284842.PubMed
44.
go back to reference Maes M: "Functional" or "psychosomatic" symptoms, for example a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression. Neuro Endocrinol Lett. 2009, 30: 564-573.PubMed Maes M: "Functional" or "psychosomatic" symptoms, for example a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression. Neuro Endocrinol Lett. 2009, 30: 564-573.PubMed
45.
go back to reference Rausch JL, Johnson ME, Corley KM, Hobby HM, Shendarkar N, Fei Y, Ganapathy V, Leibach FH: Depressed patients have higher body temperature: 5-HT transporter long promoter region effects. Neuropsychobiology. 2003, 47: 120-127. 10.1159/000070579.PubMed Rausch JL, Johnson ME, Corley KM, Hobby HM, Shendarkar N, Fei Y, Ganapathy V, Leibach FH: Depressed patients have higher body temperature: 5-HT transporter long promoter region effects. Neuropsychobiology. 2003, 47: 120-127. 10.1159/000070579.PubMed
46.
go back to reference Szuba MP, Guze BH, Baxter LR: Electroconvulsive therapy increases circadian amplitude and lowers core body temperature in depressed subjects. Biol Psychiatry. 1997, 42: 1130-1137. 10.1016/S0006-3223(97)00046-2.PubMed Szuba MP, Guze BH, Baxter LR: Electroconvulsive therapy increases circadian amplitude and lowers core body temperature in depressed subjects. Biol Psychiatry. 1997, 42: 1130-1137. 10.1016/S0006-3223(97)00046-2.PubMed
47.
go back to reference Boland RJ, Keller MB: The course of depression. Neuropsychopharmacology, the 5th Generation of Progress. Edited by: Davis KL, Charney D, Coyle JT, Nemeroff C. 2002, New York: American College of Neuropsychopharmacology, 1009-1015. Boland RJ, Keller MB: The course of depression. Neuropsychopharmacology, the 5th Generation of Progress. Edited by: Davis KL, Charney D, Coyle JT, Nemeroff C. 2002, New York: American College of Neuropsychopharmacology, 1009-1015.
48.
go back to reference Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P: Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007, 9: 671-678. 10.1111/j.1399-5618.2007.00484.x.PubMed Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P: Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007, 9: 671-678. 10.1111/j.1399-5618.2007.00484.x.PubMed
49.
go back to reference Berk M, Hallam KT, McGorry PD: The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord. 2007, 100: 279-281. 10.1016/j.jad.2007.03.007.PubMed Berk M, Hallam KT, McGorry PD: The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord. 2007, 100: 279-281. 10.1016/j.jad.2007.03.007.PubMed
50.
go back to reference Berlim MT, Turecki G: What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol. 2007, 17: 696-707. 10.1016/j.euroneuro.2007.03.009.PubMed Berlim MT, Turecki G: What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol. 2007, 17: 696-707. 10.1016/j.euroneuro.2007.03.009.PubMed
51.
go back to reference Caliyurt O, Altiay G: Resting energy expenditure in manic episode. Bipolar Disord. 2009, 11: 102-106. 10.1111/j.1399-5618.2008.00649.x.PubMed Caliyurt O, Altiay G: Resting energy expenditure in manic episode. Bipolar Disord. 2009, 11: 102-106. 10.1111/j.1399-5618.2008.00649.x.PubMed
52.
go back to reference Moylan S, Maes M, Wray NR, Berk M: The neuroprogressive nature of Major Depressive Disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. Moylan S, Maes M, Wray NR, Berk M: The neuroprogressive nature of Major Depressive Disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry.
53.
go back to reference Kessing LV: Severity of depressive episodes during the course of depressive disorder. Brit J Psychiatry. 2008, 192: 290-293. 10.1192/bjp.bp.107.038935. Kessing LV: Severity of depressive episodes during the course of depressive disorder. Brit J Psychiatry. 2008, 192: 290-293. 10.1192/bjp.bp.107.038935.
54.
go back to reference Kessing LV, Andersen PK: Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?. J Neurol Neurosurg Psychiatry. 2004, 75: 1662-1666. 10.1136/jnnp.2003.031773.PubMedPubMedCentral Kessing LV, Andersen PK: Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?. J Neurol Neurosurg Psychiatry. 2004, 75: 1662-1666. 10.1136/jnnp.2003.031773.PubMedPubMedCentral
55.
go back to reference Post RM, Rubinow DR, Ballenger JC: Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry. 1986, 149: 191-201. 10.1192/bjp.149.2.191.PubMed Post RM, Rubinow DR, Ballenger JC: Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry. 1986, 149: 191-201. 10.1192/bjp.149.2.191.PubMed
56.
go back to reference Antelman SM, Levine J, Gershon S: Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic. Mol Psychiatry. 2000, 5: 350-356. 10.1038/sj.mp.4000721.PubMed Antelman SM, Levine J, Gershon S: Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic. Mol Psychiatry. 2000, 5: 350-356. 10.1038/sj.mp.4000721.PubMed
57.
go back to reference Bell IR, Hardin EE, Baldwin CM, Schwartz GE: Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities. Environ Res. 1995, 70: 84-97. 10.1006/enrs.1995.1052.PubMed Bell IR, Hardin EE, Baldwin CM, Schwartz GE: Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities. Environ Res. 1995, 70: 84-97. 10.1006/enrs.1995.1052.PubMed
58.
go back to reference Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'anna M, Grassi-Oliveira R, Post RM: Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008, 32: 675-692. 10.1016/j.neubiorev.2007.10.005.PubMed Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'anna M, Grassi-Oliveira R, Post RM: Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008, 32: 675-692. 10.1016/j.neubiorev.2007.10.005.PubMed
59.
go back to reference Sato T, Bottlender R, Sievers M, Möller HJ: Distinct seasonality of depressive episodes differentiates unipolar depressive patients with and without depressive mixed states. J Affect Disord. 2006, 90: 1-5. 10.1016/j.jad.2005.09.009.PubMed Sato T, Bottlender R, Sievers M, Möller HJ: Distinct seasonality of depressive episodes differentiates unipolar depressive patients with and without depressive mixed states. J Affect Disord. 2006, 90: 1-5. 10.1016/j.jad.2005.09.009.PubMed
60.
go back to reference Sylvén SM, Papadopoulos FC, Olovsson M, Ekselius L, Poromaa IS, Skalkidou A: Seasonality patterns in postpartum depression. Am J Obstet Gynecol. 2011, 204: 413.e1-6. 10.1016/j.ajog.2011.01.022. Sylvén SM, Papadopoulos FC, Olovsson M, Ekselius L, Poromaa IS, Skalkidou A: Seasonality patterns in postpartum depression. Am J Obstet Gynecol. 2011, 204: 413.e1-6. 10.1016/j.ajog.2011.01.022.
61.
go back to reference Maes M, Cosyns P, Meltzer HY, De Meyer F, Peeters D: Seasonality in violent suicide but not in nonviolent suicide or homicide. Am J Psychiatry. 1993, 150: 1380-1385.PubMed Maes M, Cosyns P, Meltzer HY, De Meyer F, Peeters D: Seasonality in violent suicide but not in nonviolent suicide or homicide. Am J Psychiatry. 1993, 150: 1380-1385.PubMed
62.
go back to reference Stone EA, Lehmann ML, Lin Y, Quartermain D: Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior. Biol Psychiatry. 2006, 60: 803-811. 10.1016/j.biopsych.2006.04.020.PubMed Stone EA, Lehmann ML, Lin Y, Quartermain D: Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior. Biol Psychiatry. 2006, 60: 803-811. 10.1016/j.biopsych.2006.04.020.PubMed
63.
go back to reference Gaykema RPA, Park S-M, McKibbin CR, Goehler LE: Lipopolysaccharide suppresses activation of the tuberomammillary histaminergic system concomitant with behavior: a novel target of immune-sensory pathways. Neuroscience. 2008, 152: 273-287. 10.1016/j.neuroscience.2007.10.042.PubMedPubMedCentral Gaykema RPA, Park S-M, McKibbin CR, Goehler LE: Lipopolysaccharide suppresses activation of the tuberomammillary histaminergic system concomitant with behavior: a novel target of immune-sensory pathways. Neuroscience. 2008, 152: 273-287. 10.1016/j.neuroscience.2007.10.042.PubMedPubMedCentral
64.
go back to reference Bower JE, Ganz PA, Aziz N, Fahey JL: Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002, 64: 604-611.PubMed Bower JE, Ganz PA, Aziz N, Fahey JL: Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002, 64: 604-611.PubMed
65.
go back to reference Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M: In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 744-759. 10.1016/j.pnpbp.2010.08.026.PubMed Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M: In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 744-759. 10.1016/j.pnpbp.2010.08.026.PubMed
66.
go back to reference Leonard BE, Song C: Changes in the immune system in rodent models of depression. Int J Neuropsychopharmacol. 2002, 5: 345-356. 10.1017/S1461145702003140.PubMed Leonard BE, Song C: Changes in the immune system in rodent models of depression. Int J Neuropsychopharmacol. 2002, 5: 345-356. 10.1017/S1461145702003140.PubMed
67.
go back to reference Song C, Leonard BE: The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev. 2005, 29: 627-647. 10.1016/j.neubiorev.2005.03.010.PubMed Song C, Leonard BE: The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev. 2005, 29: 627-647. 10.1016/j.neubiorev.2005.03.010.PubMed
68.
go back to reference Gaykema RPA, Goehler LE: Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: their potential role in sickness behavior. Brain Behav Immun. 2009, 23: 926-930. 10.1016/j.bbi.2009.03.005.PubMedPubMedCentral Gaykema RPA, Goehler LE: Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: their potential role in sickness behavior. Brain Behav Immun. 2009, 23: 926-930. 10.1016/j.bbi.2009.03.005.PubMedPubMedCentral
69.
go back to reference Gaykema RPA, Goehler LE: Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue?. Brain Behav Immun. 2011, 25: 443-460. 10.1016/j.bbi.2010.11.005.PubMed Gaykema RPA, Goehler LE: Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue?. Brain Behav Immun. 2011, 25: 443-460. 10.1016/j.bbi.2010.11.005.PubMed
70.
go back to reference Anisman H, Merali Z: Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol. 1999, 461: 199-233. 10.1007/978-0-585-37970-8_12.PubMed Anisman H, Merali Z: Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol. 1999, 461: 199-233. 10.1007/978-0-585-37970-8_12.PubMed
71.
go back to reference Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE: Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav. 2006, 89: 350-357. 10.1016/j.physbeh.2006.06.019.PubMed Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE: Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav. 2006, 89: 350-357. 10.1016/j.physbeh.2006.06.019.PubMed
72.
go back to reference Goehler LE, Lyte M, Gaykema RP: Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav Immun. 2007, 21: 721-726. 10.1016/j.bbi.2007.02.005.PubMedPubMedCentral Goehler LE, Lyte M, Gaykema RP: Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology. Brain Behav Immun. 2007, 21: 721-726. 10.1016/j.bbi.2007.02.005.PubMedPubMedCentral
73.
go back to reference Castex N, Fioramonti J, Fargeas MJ, Bueno L: c-fos expression in specific rat brain nuclei after intestinal anaphylaxis: involvement of 5-HT3 receptors and vagal afferent fibers. Brain Res. 1995, 688: 149-160. 10.1016/0006-8993(95)00526-V.PubMed Castex N, Fioramonti J, Fargeas MJ, Bueno L: c-fos expression in specific rat brain nuclei after intestinal anaphylaxis: involvement of 5-HT3 receptors and vagal afferent fibers. Brain Res. 1995, 688: 149-160. 10.1016/0006-8993(95)00526-V.PubMed
74.
go back to reference Rossi-George A, Urbach D, Colas D, Goldfarb Y, Kusnecov AW: Neuronal, endocrine, and anorexic responses to the T-cell superantigen staphylococcal enterotoxin A: dependence on tumor necrosis factor-alpha. J Neurosci. 2005, 25: 5314-5322. 10.1523/JNEUROSCI.0687-05.2005.PubMed Rossi-George A, Urbach D, Colas D, Goldfarb Y, Kusnecov AW: Neuronal, endocrine, and anorexic responses to the T-cell superantigen staphylococcal enterotoxin A: dependence on tumor necrosis factor-alpha. J Neurosci. 2005, 25: 5314-5322. 10.1523/JNEUROSCI.0687-05.2005.PubMed
75.
go back to reference Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, Lyte M: Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun. 2005, 19: 334-344. 10.1016/j.bbi.2004.09.002.PubMed Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, Lyte M: Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun. 2005, 19: 334-344. 10.1016/j.bbi.2004.09.002.PubMed
76.
go back to reference Grossberg AJ, Zhu X, Leinninger GM, Levasseur PR, Braun TP, Myers MG, Marks DL: Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci. 2011, 31: 11376-11386. 10.1523/JNEUROSCI.2311-11.2011.PubMedPubMedCentral Grossberg AJ, Zhu X, Leinninger GM, Levasseur PR, Braun TP, Myers MG, Marks DL: Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci. 2011, 31: 11376-11386. 10.1523/JNEUROSCI.2311-11.2011.PubMedPubMedCentral
77.
go back to reference Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J: Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology. 1990, 24: 115-120. 10.1159/000119472.PubMed Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J: Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology. 1990, 24: 115-120. 10.1159/000119472.PubMed
78.
go back to reference Maes M: Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 664-675. 10.1016/j.pnpbp.2010.06.014.PubMed Maes M: Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 664-675. 10.1016/j.pnpbp.2010.06.014.PubMed
79.
go back to reference Howren MB, Lamkin DM, Suls J: Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009, 71: 171-186. 10.1097/PSY.0b013e3181907c1b.PubMed Howren MB, Lamkin DM, Suls J: Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009, 71: 171-186. 10.1097/PSY.0b013e3181907c1b.PubMed
80.
go back to reference Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E: Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry. 1999, 45: 833-839. 10.1016/S0006-3223(98)00131-0.PubMed Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E: Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry. 1999, 45: 833-839. 10.1016/S0006-3223(98)00131-0.PubMed
81.
go back to reference Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M, Egyed B, Bosmans E, Meltzer HY, Maes M: Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res. 2001, 105: 45-55. 10.1016/S0165-1781(01)00315-8.PubMed Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M, Egyed B, Bosmans E, Meltzer HY, Maes M: Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res. 2001, 105: 45-55. 10.1016/S0165-1781(01)00315-8.PubMed
82.
go back to reference Wichers MC, Kenis G, Koek GH, Robaeys G, Nicolson NA, Maes M: Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res. 2007, 62: 207-214. 10.1016/j.jpsychores.2006.09.007.PubMed Wichers MC, Kenis G, Koek GH, Robaeys G, Nicolson NA, Maes M: Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. J Psychosom Res. 2007, 62: 207-214. 10.1016/j.jpsychores.2006.09.007.PubMed
83.
go back to reference Anisman H: Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci. 2009, 34: 4-20.PubMedPubMedCentral Anisman H: Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci. 2009, 34: 4-20.PubMedPubMedCentral
84.
go back to reference Piser TM: Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants. Brain Behav Immun. 2010, 24: 515-524. 10.1016/j.bbi.2010.02.006.PubMed Piser TM: Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants. Brain Behav Immun. 2010, 24: 515-524. 10.1016/j.bbi.2010.02.006.PubMed
85.
go back to reference Swiergiel AH, Dunn AJ: Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav. 2007, 86: 651-659. 10.1016/j.pbb.2007.02.010.PubMedPubMedCentral Swiergiel AH, Dunn AJ: Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav. 2007, 86: 651-659. 10.1016/j.pbb.2007.02.010.PubMedPubMedCentral
86.
go back to reference Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J, Kelley KW, Dantzer R, Castanon N: Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinol. 2007, 32: 516-531. 10.1016/j.psyneuen.2007.03.005. Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J, Kelley KW, Dantzer R, Castanon N: Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinol. 2007, 32: 516-531. 10.1016/j.psyneuen.2007.03.005.
87.
go back to reference Lacosta S, Merali Z, Anisman H: Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety. Behav Neurosci. 1999, 113: 1030-1041.PubMed Lacosta S, Merali Z, Anisman H: Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety. Behav Neurosci. 1999, 113: 1030-1041.PubMed
88.
go back to reference Song C, Phillips AG, Leonard B: Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids. Eur J Neurosci. 2003, 18: 1739-1743. 10.1046/j.1460-9568.2003.02886.x.PubMed Song C, Phillips AG, Leonard B: Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids. Eur J Neurosci. 2003, 18: 1739-1743. 10.1046/j.1460-9568.2003.02886.x.PubMed
89.
go back to reference Nathan C: Points of control in inflammation. Nature. 2002, 420: 846-852. 10.1038/nature01320.PubMed Nathan C: Points of control in inflammation. Nature. 2002, 420: 846-852. 10.1038/nature01320.PubMed
90.
go back to reference Adib-Conquy M, Cavaillon JM: Compensatory anti-inflammatory response syndrome. Thromb Haemost. 2009, 101: 36-47.PubMed Adib-Conquy M, Cavaillon JM: Compensatory anti-inflammatory response syndrome. Thromb Haemost. 2009, 101: 36-47.PubMed
91.
go back to reference Tracey KJ: The inflammatory reflex. Nature. 2002, 420: 853-859. 10.1038/nature01321. ReviewPubMed Tracey KJ: The inflammatory reflex. Nature. 2002, 420: 853-859. 10.1038/nature01321. ReviewPubMed
92.
go back to reference Bone RC: Important new findings in sepsis. JAMA. 1997, 278: 249-10.1001/jama.1997.03550030089042.PubMed Bone RC: Important new findings in sepsis. JAMA. 1997, 278: 249-10.1001/jama.1997.03550030089042.PubMed
94.
go back to reference Maes M, Meltzer HY, Scharpé S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns P: Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res. 1993, 49: 151-165. 10.1016/0165-1781(93)90102-M.PubMed Maes M, Meltzer HY, Scharpé S, Bosmans E, Suy E, De Meester I, Calabrese J, Cosyns P: Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Res. 1993, 49: 151-165. 10.1016/0165-1781(93)90102-M.PubMed
95.
go back to reference Maes M, Scharpé S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche BV, Cosyns P: Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res. 1994, 54: 143-160. 10.1016/0165-1781(94)90003-5.PubMed Maes M, Scharpé S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche BV, Cosyns P: Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res. 1994, 54: 143-160. 10.1016/0165-1781(94)90003-5.PubMed
96.
go back to reference Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R: The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 702-721. 10.1016/j.pnpbp.2010.12.017.PubMed Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R: The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 702-721. 10.1016/j.pnpbp.2010.12.017.PubMed
97.
go back to reference Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M: The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord. 1998, 49: 211-219. 10.1016/S0165-0327(98)00025-1.PubMed Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M: The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord. 1998, 49: 211-219. 10.1016/S0165-0327(98)00025-1.PubMed
98.
go back to reference Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H: Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler. 1989, 370: 1063-1069. 10.1515/bchm3.1989.370.2.1063.PubMed Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H: Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler. 1989, 370: 1063-1069. 10.1515/bchm3.1989.370.2.1063.PubMed
99.
go back to reference Takikawa O, Yoshida R, Yasui H, Hayaishi O: The relationship between plasma kynurenine and indoleamine 2,3-dioxygenase activity in the extrahepatic tissues. Progress in Tryptophan and Serotonin Research. Edited by: Schlossberger HG, Kochen W, Linzen B, Steinhart H. 1984, Berlin-New York: Walter de Gruyter and Co, 517-520. Takikawa O, Yoshida R, Yasui H, Hayaishi O: The relationship between plasma kynurenine and indoleamine 2,3-dioxygenase activity in the extrahepatic tissues. Progress in Tryptophan and Serotonin Research. Edited by: Schlossberger HG, Kochen W, Linzen B, Steinhart H. 1984, Berlin-New York: Walter de Gruyter and Co, 517-520.
100.
go back to reference Moroni F, Russi P, Gallo-Mezo MA, Moneti G, Pellicciari R: Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. J Neurochem. 1991, 57: 1630-1635. 10.1111/j.1471-4159.1991.tb06361.x.PubMed Moroni F, Russi P, Gallo-Mezo MA, Moneti G, Pellicciari R: Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. J Neurochem. 1991, 57: 1630-1635. 10.1111/j.1471-4159.1991.tb06361.x.PubMed
101.
go back to reference Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M: Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol. 2002, 22: 86-90. 10.1097/00004714-200202000-00014.PubMed Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M: Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol. 2002, 22: 86-90. 10.1097/00004714-200202000-00014.PubMed
102.
go back to reference Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpé S: Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci. 2002, 71: 1837-1848. 10.1016/S0024-3205(02)01853-2.PubMed Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpé S: Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci. 2002, 71: 1837-1848. 10.1016/S0024-3205(02)01853-2.PubMed
103.
go back to reference Toker L, Amar S, Bersudsky Y, Benjamin J, Klein E: The biology of tryptophan depletion and mood disorders. Isr J Psychiatry Relat Sci. 2010, 47: 46-55.PubMed Toker L, Amar S, Bersudsky Y, Benjamin J, Klein E: The biology of tryptophan depletion and mood disorders. Isr J Psychiatry Relat Sci. 2010, 47: 46-55.PubMed
104.
go back to reference O'Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R: Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci. 2009, 29: 4200-4209. 10.1523/JNEUROSCI.5032-08.2009.PubMedPubMedCentral O'Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R: Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci. 2009, 29: 4200-4209. 10.1523/JNEUROSCI.5032-08.2009.PubMedPubMedCentral
105.
go back to reference Hoes MJ: The clinical significance of an elevated excretion of xanthurenic acid in psychiatric patients. Acta Psychiatr Belg. 1979, 79: 638-646.PubMed Hoes MJ: The clinical significance of an elevated excretion of xanthurenic acid in psychiatric patients. Acta Psychiatr Belg. 1979, 79: 638-646.PubMed
106.
go back to reference Møller SE, Kirk L, Honoré P: Tryptophan tolerance and metabolism in endogenous depression. Psychopharmacology (Berl). 1982, 76: 79-83. 10.1007/BF00430761. Møller SE, Kirk L, Honoré P: Tryptophan tolerance and metabolism in endogenous depression. Psychopharmacology (Berl). 1982, 76: 79-83. 10.1007/BF00430761.
107.
go back to reference Maes M, De Ruyter M, Suy E: Xanthurenic acid flow in 24-hour urine following L-tryptophan loading in depressive patients. Acta Psychiatr Belg. 1986, 86: 120-130.PubMed Maes M, De Ruyter M, Suy E: Xanthurenic acid flow in 24-hour urine following L-tryptophan loading in depressive patients. Acta Psychiatr Belg. 1986, 86: 120-130.PubMed
108.
go back to reference Maes M, De Ruyter M, Suy E: The renal excretion of xanthurenic acid following L-tryptophan loading in depressed patients. Hum Psychopharmacol Clin Exp. 1987, 2: 231-235. 10.1002/hup.470020406. Maes M, De Ruyter M, Suy E: The renal excretion of xanthurenic acid following L-tryptophan loading in depressed patients. Hum Psychopharmacol Clin Exp. 1987, 2: 231-235. 10.1002/hup.470020406.
109.
go back to reference Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B: Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord. 2007, 98: 143-151. 10.1016/j.jad.2006.07.013.PubMed Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B: Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord. 2007, 98: 143-151. 10.1016/j.jad.2006.07.013.PubMed
110.
go back to reference Gabbay V, Klein RG, Katz Y, Mendoza S, Guttman LE, Alonso CM, Babb JS, Hirsch GS, Liebes L: The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry. 2010, 51: 935-943. 10.1111/j.1469-7610.2010.02245.x.PubMedPubMedCentral Gabbay V, Klein RG, Katz Y, Mendoza S, Guttman LE, Alonso CM, Babb JS, Hirsch GS, Liebes L: The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry. 2010, 51: 935-943. 10.1111/j.1469-7610.2010.02245.x.PubMedPubMedCentral
111.
go back to reference Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, Mawrin C, Brisch R, Bielau H, Meyer zu Schwabedissen L, Bogerts B, Myint AM: Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?. J Neuroinflammation. 2011, 8: 94-10.1186/1742-2094-8-94.PubMedPubMedCentral Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, Mawrin C, Brisch R, Bielau H, Meyer zu Schwabedissen L, Bogerts B, Myint AM: Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?. J Neuroinflammation. 2011, 8: 94-10.1186/1742-2094-8-94.PubMedPubMedCentral
112.
go back to reference Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, Mann JJ, Postolache TT: Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun. 2011, 25: 1272-1278. 10.1016/j.bbi.2011.05.002.PubMedPubMedCentral Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, Mann JJ, Postolache TT: Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun. 2011, 25: 1272-1278. 10.1016/j.bbi.2011.05.002.PubMedPubMedCentral
113.
go back to reference Anderson G, Maes M, Berk M: Biological underpinnings of the commonalities in depression, somatization, and chronic fatigue syndrome. Med Hypotheses. 2012, 78: 752-756. 10.1016/j.mehy.2012.02.023.PubMed Anderson G, Maes M, Berk M: Biological underpinnings of the commonalities in depression, somatization, and chronic fatigue syndrome. Med Hypotheses. 2012, 78: 752-756. 10.1016/j.mehy.2012.02.023.PubMed
114.
go back to reference Celik C, Erdem M, Cayci T, Ozdemir B, Ozgur Akgul E, Kurt YG, Yaman H, Isintas M, Ozgen F, Ozsahin A: The association between serum levels of neopterin and number of depressive episodes of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010, 34: 372-375. 10.1016/j.pnpbp.2010.01.002.PubMed Celik C, Erdem M, Cayci T, Ozdemir B, Ozgur Akgul E, Kurt YG, Yaman H, Isintas M, Ozgen F, Ozsahin A: The association between serum levels of neopterin and number of depressive episodes of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010, 34: 372-375. 10.1016/j.pnpbp.2010.01.002.PubMed
115.
go back to reference Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E: The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord. 2001, 63: 85-92. 10.1016/S0165-0327(00)00156-7.PubMed Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E: The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord. 2001, 63: 85-92. 10.1016/S0165-0327(00)00156-7.PubMed
116.
go back to reference Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Räsänen P, Leinonen M, Meyer-Rochow VB, Timonen M: The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry. 2006, 60: 825-830. 10.1016/j.biopsych.2006.02.016.PubMed Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Räsänen P, Leinonen M, Meyer-Rochow VB, Timonen M: The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry. 2006, 60: 825-830. 10.1016/j.biopsych.2006.02.016.PubMed
117.
go back to reference Hennessy MB, Paik KD, Caraway JD, Schiml PA, Deak T: Proinflammatory activity and the sensitization of depressive-like behavior during maternal separation. Behav Neurosci. 2011, 125: 426-433.PubMedPubMedCentral Hennessy MB, Paik KD, Caraway JD, Schiml PA, Deak T: Proinflammatory activity and the sensitization of depressive-like behavior during maternal separation. Behav Neurosci. 2011, 125: 426-433.PubMedPubMedCentral
118.
go back to reference Kawasaki Y, Zhang L, Cheng JK, Ji RR: Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008, 28: 5189-5194. 10.1523/JNEUROSCI.3338-07.2008.PubMedPubMedCentral Kawasaki Y, Zhang L, Cheng JK, Ji RR: Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008, 28: 5189-5194. 10.1523/JNEUROSCI.3338-07.2008.PubMedPubMedCentral
119.
go back to reference Maes M, Ringel K, Kubera M, Berk M, Rybakowski J: Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord. 2012, 136: 386-392. 10.1016/j.jad.2011.11.016.PubMed Maes M, Ringel K, Kubera M, Berk M, Rybakowski J: Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord. 2012, 136: 386-392. 10.1016/j.jad.2011.11.016.PubMed
120.
go back to reference Hochstrasser T, Ullrich C, Sperner-Unterweger B, Humpel C: Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices. Neuroscience. 2011, 184: 128-138.PubMed Hochstrasser T, Ullrich C, Sperner-Unterweger B, Humpel C: Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices. Neuroscience. 2011, 184: 128-138.PubMed
121.
go back to reference Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997, 9: 853-858. 10.1006/cyto.1997.0238.PubMed Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997, 9: 853-858. 10.1006/cyto.1997.0238.PubMed
122.
go back to reference Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R: Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry. 1997, 42: 349-358. 10.1016/S0006-3223(96)00365-4.PubMed Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R: Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry. 1997, 42: 349-358. 10.1016/S0006-3223(96)00365-4.PubMed
123.
go back to reference Kubera M, Van Bockstaele D, Maes M: Leukocyte subsets in treatment-resistant major depression. Pol J Pharmacol. 1999, 51: 547-549.PubMed Kubera M, Van Bockstaele D, Maes M: Leukocyte subsets in treatment-resistant major depression. Pol J Pharmacol. 1999, 51: 547-549.PubMed
124.
go back to reference O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG: Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res. 2007, 41: 326-331. 10.1016/j.jpsychires.2006.05.013.PubMed O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG: Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res. 2007, 41: 326-331. 10.1016/j.jpsychires.2006.05.013.PubMed
125.
go back to reference Jacka FN, Maes M, Pasco JA, Williams LJ, Berk M: Nutrient intakes and the common mental disorders in women. J Affect Disord. Jacka FN, Maes M, Pasco JA, Williams LJ, Berk M: Nutrient intakes and the common mental disorders in women. J Affect Disord.
126.
go back to reference Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M: The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009, 24: 27-53. 10.1007/s11011-008-9118-1.PubMed Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M: The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009, 24: 27-53. 10.1007/s11011-008-9118-1.PubMed
127.
go back to reference Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY: Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995, 29: 141-152. 10.1016/0022-3956(94)00049-W.PubMed Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY: Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995, 29: 141-152. 10.1016/0022-3956(94)00049-W.PubMed
128.
go back to reference Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpé S: Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 1997, 66: 1-11. 10.1016/S0165-1781(96)02915-0.PubMed Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpé S: Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 1997, 66: 1-11. 10.1016/S0165-1781(96)02915-0.PubMed
129.
go back to reference Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ: Immunologic variables in acute mania of bipolar disorder. J Neuroimmunol. 2004, 150: 116-122. 10.1016/j.jneuroim.2004.01.006.PubMed Liu HC, Yang YY, Chou YM, Chen KP, Shen WW, Leu SJ: Immunologic variables in acute mania of bipolar disorder. J Neuroimmunol. 2004, 150: 116-122. 10.1016/j.jneuroim.2004.01.006.PubMed
130.
go back to reference Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M: Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol. 2002, 17: 175-179. 10.1002/hup.390.PubMed Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M: Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol. 2002, 17: 175-179. 10.1002/hup.390.PubMed
131.
go back to reference Maes M, Galecki P, Chang YS, Berk M: A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 676-692. 10.1016/j.pnpbp.2010.05.004.PubMed Maes M, Galecki P, Chang YS, Berk M: A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 676-692. 10.1016/j.pnpbp.2010.05.004.PubMed
132.
go back to reference Maes M, Mihaylova I, Leunis JC: Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett. 2007, 28: 861-867.PubMed Maes M, Mihaylova I, Leunis JC: Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett. 2007, 28: 861-867.PubMed
133.
go back to reference Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M: IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord. 2012, 135: 414-418. Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M: IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord. 2012, 135: 414-418.
134.
go back to reference Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M: Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychol Med. 2005, 35: 433-441. 10.1017/S0033291704003526.PubMed Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M: Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychol Med. 2005, 35: 433-441. 10.1017/S0033291704003526.PubMed
135.
go back to reference Leonard BE, Myint A: Inflammation and depression: is there a causal connection with dementia?. Neurotox Res. 2006, 10: 149-160. 10.1007/BF03033243.PubMed Leonard BE, Myint A: Inflammation and depression: is there a causal connection with dementia?. Neurotox Res. 2006, 10: 149-160. 10.1007/BF03033243.PubMed
136.
go back to reference Song C, Wang H: Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 760-768. 10.1016/j.pnpbp.2010.06.020.PubMed Song C, Wang H: Cytokines mediated inflammation and decreased neurogenesis in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 760-768. 10.1016/j.pnpbp.2010.06.020.PubMed
137.
go back to reference Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D: Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?. Curr Med Chem. 2011, 18: 245-255. 10.2174/092986711794088353.PubMed Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D: Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?. Curr Med Chem. 2011, 18: 245-255. 10.2174/092986711794088353.PubMed
138.
go back to reference Gorwood P, Corruble E, Falissard B, Goodwin GM: Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry. 2008, 165: 731-739. 10.1176/appi.ajp.2008.07040574.PubMed Gorwood P, Corruble E, Falissard B, Goodwin GM: Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry. 2008, 165: 731-739. 10.1176/appi.ajp.2008.07040574.PubMed
139.
go back to reference Lampe IK, Hulshoff Pol HE, Janssen J, Schnack HG, Kahn RS, Heeren TJ: Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder. Am J Psychiatry. 2003, 160: 2052-2054. 10.1176/appi.ajp.160.11.2052.PubMed Lampe IK, Hulshoff Pol HE, Janssen J, Schnack HG, Kahn RS, Heeren TJ: Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder. Am J Psychiatry. 2003, 160: 2052-2054. 10.1176/appi.ajp.160.11.2052.PubMed
140.
go back to reference McKinnon MC, Yucel K, Nazarov A, MacQueen GM: A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci. 2009, 34: 41-54.PubMedPubMedCentral McKinnon MC, Yucel K, Nazarov A, MacQueen GM: A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci. 2009, 34: 41-54.PubMedPubMedCentral
141.
go back to reference Videbech P, Ravnkilde B: Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004, 161: 1957-1966. 10.1176/appi.ajp.161.11.1957.PubMed Videbech P, Ravnkilde B: Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004, 161: 1957-1966. 10.1176/appi.ajp.161.11.1957.PubMed
142.
go back to reference MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT: Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA. 2003, 100: 1387-1392. 10.1073/pnas.0337481100.PubMedPubMedCentral MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT: Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA. 2003, 100: 1387-1392. 10.1073/pnas.0337481100.PubMedPubMedCentral
143.
go back to reference Lacerda AL, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC: Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res. 2003, 124: 129-140. 10.1016/S0925-4927(03)00123-9.PubMed Lacerda AL, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC: Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res. 2003, 124: 129-140. 10.1016/S0925-4927(03)00123-9.PubMed
144.
go back to reference Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, Friedman L, Rajkowska G: Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry. 2004, 56: 640-650. 10.1016/j.biopsych.2004.08.022.PubMedPubMedCentral Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, Friedman L, Rajkowska G: Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry. 2004, 56: 640-650. 10.1016/j.biopsych.2004.08.022.PubMedPubMedCentral
145.
go back to reference Drevets WC, Price JL, Furey ML: Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008, 213: 93-118. 10.1007/s00429-008-0189-x.PubMedPubMedCentral Drevets WC, Price JL, Furey ML: Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008, 213: 93-118. 10.1007/s00429-008-0189-x.PubMedPubMedCentral
146.
go back to reference Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD: Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009, 66: 407-414. 10.1016/j.biopsych.2009.03.015.PubMedPubMedCentral Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD: Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009, 66: 407-414. 10.1016/j.biopsych.2009.03.015.PubMedPubMedCentral
147.
go back to reference Koenigs M, Grafman J: The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res. 2009, 201: 239-243. 10.1016/j.bbr.2009.03.004.PubMedPubMedCentral Koenigs M, Grafman J: The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res. 2009, 201: 239-243. 10.1016/j.bbr.2009.03.004.PubMedPubMedCentral
148.
go back to reference Park S-M, Gaykema RPA, Goehler LE: How does immune challenge inhibit ingestion of palatable food? Systemic lipopolysaccharide modulates key nodal points of feeding neurocircuitry. Brain Behav Immun. 2008, 22: 1160-1172. 10.1016/j.bbi.2008.05.001.PubMedPubMedCentral Park S-M, Gaykema RPA, Goehler LE: How does immune challenge inhibit ingestion of palatable food? Systemic lipopolysaccharide modulates key nodal points of feeding neurocircuitry. Brain Behav Immun. 2008, 22: 1160-1172. 10.1016/j.bbi.2008.05.001.PubMedPubMedCentral
149.
go back to reference Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN: Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009, 12: 447-458. 10.1017/S1461145708009310.PubMed Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN: Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009, 12: 447-458. 10.1017/S1461145708009310.PubMed
150.
go back to reference Jancsár SM, Leonard BE: The effects of antidepressant drugs on conditioned taste aversion learning of the olfactory bulbectomized rat. Neuropharmacology. 1981, 20: 1341-1345.PubMed Jancsár SM, Leonard BE: The effects of antidepressant drugs on conditioned taste aversion learning of the olfactory bulbectomized rat. Neuropharmacology. 1981, 20: 1341-1345.PubMed
151.
go back to reference Kumar RK, Wakefield D: Inflammation: chronic. eLS. 2010, DOI: 10.1002/9780470015902. a0000944. {ED Query: I couldn't find this ref. in PubMed so left it as is.} Kumar RK, Wakefield D: Inflammation: chronic. eLS. 2010, DOI: 10.1002/9780470015902. a0000944. {ED Query: I couldn't find this ref. in PubMed so left it as is.}
152.
go back to reference Straub RH: Evolutionary medicine and chronic inflammatory state-known and new concepts in pathophysiology. J Mol Med (Berl). 2012, 90: 523-534. 10.1007/s00109-012-0861-8. Straub RH: Evolutionary medicine and chronic inflammatory state-known and new concepts in pathophysiology. J Mol Med (Berl). 2012, 90: 523-534. 10.1007/s00109-012-0861-8.
153.
go back to reference Jewkes RK, Dunkle K, Nduna M, Jama PN, Puren A: Associations between childhood adversity and depression, substance abuse and HIV and HSV2 incident infections in rural South African youth. Child Abuse Negl. 2010, 34: 833-841. 10.1016/j.chiabu.2010.05.002.PubMedPubMedCentral Jewkes RK, Dunkle K, Nduna M, Jama PN, Puren A: Associations between childhood adversity and depression, substance abuse and HIV and HSV2 incident infections in rural South African youth. Child Abuse Negl. 2010, 34: 833-841. 10.1016/j.chiabu.2010.05.002.PubMedPubMedCentral
154.
go back to reference Pearce BD, Kruszon-Moran D, Jones JL: The relationship between Toxoplasma gondii infection and mood disorders in the Third National Health and Nutrition Survey. Biol Psychiatry. Pearce BD, Kruszon-Moran D, Jones JL: The relationship between Toxoplasma gondii infection and mood disorders in the Third National Health and Nutrition Survey. Biol Psychiatry.
155.
go back to reference Maes M: An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 784-794. 10.1016/j.pnpbp.2010.06.023.PubMed Maes M: An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 784-794. 10.1016/j.pnpbp.2010.06.023.PubMed
156.
go back to reference Owe-Larsson B, Säll L, Salamon E, Allgulander C: HIV infection and psychiatric illness. Afr J Psychiatry. 2009, 12: 115-128. Owe-Larsson B, Säll L, Salamon E, Allgulander C: HIV infection and psychiatric illness. Afr J Psychiatry. 2009, 12: 115-128.
157.
go back to reference Maes M, Kubera M, Leunis JC, Berk M: Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord. Maes M, Kubera M, Leunis JC, Berk M: Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord.
158.
go back to reference Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH: Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease". Am J Med. 2009, 122: 843-850. 10.1016/j.amjmed.2009.02.022.PubMedPubMedCentral Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH: Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease". Am J Med. 2009, 122: 843-850. 10.1016/j.amjmed.2009.02.022.PubMedPubMedCentral
159.
go back to reference Strijdom SC, Berk M: Lyme disease in South Africa. S Afr Med J. 1996, 86 (Suppl): 741-744.PubMed Strijdom SC, Berk M: Lyme disease in South Africa. S Afr Med J. 1996, 86 (Suppl): 741-744.PubMed
160.
go back to reference van den Pol AN: Viral infection leading to brain dysfunction: more prevalent than appreciated?. Neuron. 2009, 64: 17-20. 10.1016/j.neuron.2009.09.023.PubMedPubMedCentral van den Pol AN: Viral infection leading to brain dysfunction: more prevalent than appreciated?. Neuron. 2009, 64: 17-20. 10.1016/j.neuron.2009.09.023.PubMedPubMedCentral
161.
go back to reference Maes M, Song C, Lin A, DeJong R, Van Gastel A, Kenis G, Bosmans E, DeMeester I, Neels H, Janca A, Scharpe S, Smith RS: Immune and clinical correlates of psychological stress-induced production of interferon-γ and IL-10 in humans. Cytokines, Stress and Immunity. Edited by: Plotnikoff NP, Faith RE, Murgo AJ, Good RA. 1998, New York: Taylor and Francis, 39-50. Maes M, Song C, Lin A, DeJong R, Van Gastel A, Kenis G, Bosmans E, DeMeester I, Neels H, Janca A, Scharpe S, Smith RS: Immune and clinical correlates of psychological stress-induced production of interferon-γ and IL-10 in humans. Cytokines, Stress and Immunity. Edited by: Plotnikoff NP, Faith RE, Murgo AJ, Good RA. 1998, New York: Taylor and Francis, 39-50.
162.
go back to reference Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner LM, Bailey MT, Nelson RJ, Godbout JP, Sheridan JF: β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci. 2011, 31: 6277-6288. 10.1523/JNEUROSCI.0450-11.2011.PubMedPubMedCentral Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner LM, Bailey MT, Nelson RJ, Godbout JP, Sheridan JF: β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci. 2011, 31: 6277-6288. 10.1523/JNEUROSCI.0450-11.2011.PubMedPubMedCentral
163.
go back to reference Williams LJ, Pasco JA, Jacka FN, Henry MJ, Dodd S, Berk M: Depression and bone metabolism. A review. Psychother Psychosom. 2009, 78: 16-25. 10.1159/000162297.PubMed Williams LJ, Pasco JA, Jacka FN, Henry MJ, Dodd S, Berk M: Depression and bone metabolism. A review. Psychother Psychosom. 2009, 78: 16-25. 10.1159/000162297.PubMed
164.
go back to reference Pavlovićc Z, Delićc D, Marićc NP, Vukovićc O, Jašovićc-Gašićc M: Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study. Psychiatr Danub. 2011, 23: 370-377. Pavlovićc Z, Delićc D, Marićc NP, Vukovićc O, Jašovićc-Gašićc M: Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study. Psychiatr Danub. 2011, 23: 370-377.
165.
go back to reference Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M: IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry. 2005, 10: 538-544. 10.1038/sj.mp.4001600.PubMed Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M: IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry. 2005, 10: 538-544. 10.1038/sj.mp.4001600.PubMed
166.
go back to reference Kendler KS, Thornton LM, Gardner CO: Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry. 2001, 158: 582-586. 10.1176/appi.ajp.158.4.582.PubMed Kendler KS, Thornton LM, Gardner CO: Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry. 2001, 158: 582-586. 10.1176/appi.ajp.158.4.582.PubMed
167.
go back to reference Laugeray A, Launay JM, Callebert J, Surget A, Belzung C, Barone PR: Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: Focus on individual differences. Pharmacol Biochem Behav. 2011, 98: 161-168. 10.1016/j.pbb.2010.12.008.PubMed Laugeray A, Launay JM, Callebert J, Surget A, Belzung C, Barone PR: Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: Focus on individual differences. Pharmacol Biochem Behav. 2011, 98: 161-168. 10.1016/j.pbb.2010.12.008.PubMed
168.
go back to reference Wrynn AS, Mac Sweeney CP, Franconi F, Lemaire L, Pouliquen D, Herlidou S, Leonard BE, Gandon J, de Certaines JD: An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Res. 2000, 879: 193-199. 10.1016/S0006-8993(00)02619-6.PubMed Wrynn AS, Mac Sweeney CP, Franconi F, Lemaire L, Pouliquen D, Herlidou S, Leonard BE, Gandon J, de Certaines JD: An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Res. 2000, 879: 193-199. 10.1016/S0006-8993(00)02619-6.PubMed
169.
go back to reference Wang D, Noda Y, Tsunekawa H, Zhou Y, Miyazaki M, Senzaki K, Nabeshima T: Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav Brain Res. 2007, 178: 262-273. 10.1016/j.bbr.2007.01.003.PubMed Wang D, Noda Y, Tsunekawa H, Zhou Y, Miyazaki M, Senzaki K, Nabeshima T: Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav Brain Res. 2007, 178: 262-273. 10.1016/j.bbr.2007.01.003.PubMed
170.
go back to reference Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP: Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging. 2008, 29: 1744-1753. 10.1016/j.neurobiolaging.2007.04.012.PubMed Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP: Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging. 2008, 29: 1744-1753. 10.1016/j.neurobiolaging.2007.04.012.PubMed
171.
go back to reference Nakanishi H, Hayashi Y, Wu Z: The role of microglial mtDNA damage in age-dependent prolonged LPS-induced sickness behavior. Neuron Glia Biol. 2011, 28: 1-7. Nakanishi H, Hayashi Y, Wu Z: The role of microglial mtDNA damage in age-dependent prolonged LPS-induced sickness behavior. Neuron Glia Biol. 2011, 28: 1-7.
172.
go back to reference Taepavarapruk P, Song C: Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment. J Neurochem. 2010, 112: 1054-1064. 10.1111/j.1471-4159.2009.06524.x.PubMed Taepavarapruk P, Song C: Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment. J Neurochem. 2010, 112: 1054-1064. 10.1111/j.1471-4159.2009.06524.x.PubMed
173.
go back to reference Lai AY, Swayze RD, El-Husseini A, Song C: Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol. 2006, 175: 97-106. 10.1016/j.jneuroim.2006.03.001.PubMed Lai AY, Swayze RD, El-Husseini A, Song C: Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol. 2006, 175: 97-106. 10.1016/j.jneuroim.2006.03.001.PubMed
174.
go back to reference Kinney DK, Tanaka M: An evolutionary hypothesis of depression and its symptoms, adaptive value, and risk factors. J Nerv Ment Dis. 1980, 97: 561-567. Kinney DK, Tanaka M: An evolutionary hypothesis of depression and its symptoms, adaptive value, and risk factors. J Nerv Ment Dis. 1980, 97: 561-567.
175.
go back to reference Raison CL, Miller AH: The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatr. 2012, doi: 10.1038/mp.2012.2. PubMed PMID: 22290120 Raison CL, Miller AH: The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatr. 2012, doi: 10.1038/mp.2012.2. PubMed PMID: 22290120
176.
go back to reference Olde Hartman TC, Borghuis MS, Lucassen PL, van de Laar FA, Speckens AE, van Weel C: Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res. 2009, 66: 363-377. 10.1016/j.jpsychores.2008.09.018.PubMed Olde Hartman TC, Borghuis MS, Lucassen PL, van de Laar FA, Speckens AE, van Weel C: Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res. 2009, 66: 363-377. 10.1016/j.jpsychores.2008.09.018.PubMed
177.
go back to reference Xia Z, DePierre JW, Nassberger L: Tricyclic antidepressants inhibit IL-6, IL-1b and TNF-a release in human blood monocytes and IL-2 and interferon-g in T cells. Immunopharmacology. 1996, 34: 27-37. 10.1016/0162-3109(96)00111-7.PubMed Xia Z, DePierre JW, Nassberger L: Tricyclic antidepressants inhibit IL-6, IL-1b and TNF-a release in human blood monocytes and IL-2 and interferon-g in T cells. Immunopharmacology. 1996, 34: 27-37. 10.1016/0162-3109(96)00111-7.PubMed
178.
go back to reference Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S: Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacol. 1999, 20: 370-379. 10.1016/S0893-133X(98)00088-8. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S: Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacol. 1999, 20: 370-379. 10.1016/S0893-133X(98)00088-8.
179.
go back to reference Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MB: A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol. 2006, 6: 903-907. 10.1016/j.intimp.2005.12.007.PubMed Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MB: A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol. 2006, 6: 903-907. 10.1016/j.intimp.2005.12.007.PubMed
180.
go back to reference Castanon N, Bluthé RM, Dantzer R: Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology (Berl). 2001, 154: 50-60. 10.1007/s002130000595. Castanon N, Bluthé RM, Dantzer R: Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology (Berl). 2001, 154: 50-60. 10.1007/s002130000595.
181.
go back to reference Jiang Y, Deacon R, Anthony DC, Campbell SJ: Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol Dis. 2008, 632: 125-132. Jiang Y, Deacon R, Anthony DC, Campbell SJ: Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiol Dis. 2008, 632: 125-132.
182.
go back to reference Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. 1995, 34: 301-309. 10.1016/0165-0327(95)00028-L.PubMed Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. 1995, 34: 301-309. 10.1016/0165-0327(95)00028-L.PubMed
183.
go back to reference Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M: New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology. 2012, 20: 127-150. 10.1007/s10787-011-0111-7.PubMed Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M: New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology. 2012, 20: 127-150. 10.1007/s10787-011-0111-7.PubMed
184.
go back to reference Hannestad J, DellaGioia N, Bloch M: The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011, 36: 2452-2459. 10.1038/npp.2011.132.PubMedPubMedCentral Hannestad J, DellaGioia N, Bloch M: The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011, 36: 2452-2459. 10.1038/npp.2011.132.PubMedPubMedCentral
185.
go back to reference Kirsch I: Antidepressants and the placebo response. Epidemiol Psichiatr Soc. 2009, 18: 318-322.PubMed Kirsch I: Antidepressants and the placebo response. Epidemiol Psichiatr Soc. 2009, 18: 318-322.PubMed
186.
go back to reference Tuma T: Outcome of hospital treated depression at 4.5 years. An elderly and a younger cohort compared. Br J Psychiatry. 2000, 176: 224-228. 10.1192/bjp.176.3.224.PubMed Tuma T: Outcome of hospital treated depression at 4.5 years. An elderly and a younger cohort compared. Br J Psychiatry. 2000, 176: 224-228. 10.1192/bjp.176.3.224.PubMed
187.
go back to reference Twenge JM, Gentile B, DeWall CN, Ma D, Lacefield K, Schurtz DR: Birth cohort increases in psychopathology among young Americans, 1938-2007: A cross-temporal meta-analysis of the MMPI. Clin Psychol Rev. 2010, 30: 145-154. 10.1016/j.cpr.2009.10.005.PubMed Twenge JM, Gentile B, DeWall CN, Ma D, Lacefield K, Schurtz DR: Birth cohort increases in psychopathology among young Americans, 1938-2007: A cross-temporal meta-analysis of the MMPI. Clin Psychol Rev. 2010, 30: 145-154. 10.1016/j.cpr.2009.10.005.PubMed
Metadata
Title
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Authors
Michael Maes
Michael Berk
Lisa Goehler
Cai Song
George Anderson
Piotr Gałecki
Brian Leonard
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2012
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-10-66

Other articles of this Issue 1/2012

BMC Medicine 1/2012 Go to the issue